Encision Iterates AEM EndoShield® 2 Burn Protection System for Compatibility with New Generator Technology

BOULDER, Colo., June 3, 2016 /PRNewswire/ -- Encision Inc. (ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced the enhancement of its recently released AEM EndoShield® 2 Burn Protection System ("EndoShield 2") to interface with a market leading electrosurgical generator.

"Encision is proud to share the rapid iteration of our new EndoShield 2 to better meet our customers' needs," said Greg Trudel, President and CEO of Encision. "As we neared completion on the development of EndoShield 2, a number of our customers contacted us and requested that EndoShield 2 be adapted to work on an upcoming release of a new electrosurgical generator from a market leading company. We immediately reached out to the company and were pleased with their ready collaboration and offer to lend us a generator to do compatibility testing upon. After completing extensive testing we found that the units were electrically compatible and implemented a change to EndoShield 2 to increase its ease of use with the new generator.  Our Development, Operations and Regulatory teams worked together to deliver an important product enhancement that ensures optimal patient safety in laparoscopic surgery and compatibility with the latest in electrosurgical generator technology. It is a nice example of medical device companies collaborating to provide hospitals and their patients with the very best in safety and technology."

"Our new EndoShield 2 can be used for a number of surgical procedures without reprocessing. It reduces the cost per use significantly for our customers and eliminates a significant barrier to the adoption of AEM® Technology. The plug and play design provides greater flexibility than ever for hospitals to perform laparoscopic procedures in any open operating room without the need to move expensive capital from room to room. EndoShield 2 is the cornerstone of our growth going forward. The low cost reposable design is exactly what our worldwide customers have been asking for and what will enable us to take AEM Technology one step closer to becoming the standard of care for patient safety in laparoscopy."

Encision Inc. designs and markets a portfolio of high performance surgical instrumentation that delivers advances in patient safety with AEM technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures. Based in Boulder, CO, the company pioneered the development and deployment of Active Electrode Monitoring, AEM technology, to eliminate dangerous stray energy burns during minimally invasive procedures.

In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to develop new or enhanced products and have such products accepted in the market, delay in developing new products and receiving FDA approval for such new products, its ability to increase net sales through the Company's distribution channels, its ability to compete successfully against other manufacturers of surgical instruments, insufficient quantity of new account conversions, insufficient cash to fund operations, and other factors discussed in the Company's filings with the Securities and Exchange Commission. Readers are encouraged to review the risk factors and other disclosures appearing in the Company's Annual Report on Form 10-K for the year ended March 31, 2015 and subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements, whether as a result of the receipt of new information, future events, or otherwise.

CONTACT: Mala Ray, Encision Inc., 303-444-2600, [email protected]

SOURCE Encision Inc.